March 31, 2026

FDA Monthly Preview: Key April Decisions to Watch

Several high-stakes FDA decisions across multiple specialties are expected this month.

Conexiant

March 30, 2026

Extended Viral PCR: Does It Help?

Researchers evaluate whether extended viral PCR testing is associated with antibiotic use and length of stay in adult inpatients.

Conexiant

March 27, 2026

FDA Approves Gene Therapy for Severe Pediatric LAD-I

Approval expands treatment option for a rare pediatric immunodeficiency

Conexiant

March 27, 2026

Meningococcal Abscess Detected by MRI

MRI identifies rare intracranial complication following normal computed tomography

Conexiant

March 26, 2026

Limits of Negative Infection Studies in AD

Perspective argues that study design and measurement challenges may obscure potential links between infection and disease

Conexiant

March 25, 2026

Gonococcal Endocarditis Diagnosed by PCR

Case highlights diagnostic challenges when blood cultures are negative and embolic complications are present

Conexiant

March 25, 2026

When Guillain-Barré Signals Lyme 

A case highlights how evolving neurologic findings can prompt testing for tick-borne infection.

Conexiant

March 25, 2026

CDC Cuts: Fallout Hits Workforce

Mass layoffs, funding cuts, and violence disrupt CDC operations, raising concerns about long-term public health capacity.

KFF Health News

March 23, 2026

Lyme Vaccine Advances in Late Trial

Large global study evaluates novel prevention strategy.

Conexiant

March 23, 2026

Can Shorter TB Prevention Regimens Work?

Randomized study evaluates efficacy, safety, and completion in high-risk patients

Conexiant